Safety of CAN-3110 in patients with rHGG/rGBM
ADVERSE EVENTS, ADVERSE REACTION
Most clinical oHSVs to date have deleted or removed the viral gene encoding ICP34.5 (refs. Total adverse events (grade 1 or 2) related to CAN-3110Events reported as of 18 April 2022.Serious adverse events (grade 3 or above) possibly, likely or definitely related to CAN-3110Arm A3 × 10Arm A3 × 10Arm A1 × 10Arm A1 × 10SUSAR, suspected unexpected serious adverse reaction.